Open AccessOptimizing Regorafenib Dosing and Patient Management in Colorectal Cancer in Latin America: Perspectives from Argentina
Author(s) -
Dioca Mariano,
O'Connor Juan Manuel
Publication year - 2021
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1002/onco.13723
Subject(s) - regorafenib , medicine , colorectal cancer , latin americans , dosing , cancer , clinical trial , oncology , linguistics , philosophy
Colorectal cancer (CRC) is one of the most commonly diagnosed cancers in Central and South America and one of the top causes of cancer death; however, these rates vary considerably between countries. This commentary focuses on clinical experiences in Argentina, highlighting results of the phase II ReDOS trial.